Skip to content

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease a Randomised Triple Blind Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02782455
Enrollment
100
Registered
2016-05-25
Start date
2016-12-01
Completion date
2018-11-30
Last updated
2018-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids

Brief summary

Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When inflamed they become pathological and may present with protrusion and bleeding. A randomized, triple blind , controlled study will be conducted to compare the efficacy of calcium dobesilate against flavanoids in the management of early haemorrhoidal disease.

Interventions

Daflon is administered

DRUGCDobi

Calcium dobesylate is administered

Sponsors

Services Hospital, Lahore
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
13 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Grade I and Grade II hemorrhoids

Exclusion criteria

* CLD * colorectal/ anorectal Malignancy * self medication * local Quack Hakeem medication * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Frequency of occurrence of rectal bleeding after usage of drug1 weeksAfter the patients will be given the two drugs they will be followed for the frequency of occurrence of rectal bleeding till two weeks

Secondary

MeasureTime frameDescription
regression of hemorrhoids1 weeksPatients will under gone per rectal examination and proctoscopy to look for grades of hemorrhoids whether its has decreased or increased.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026